UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 177

Sortiert nach

Does liver tumor burden affect the therapeutic effect of 177Lu-Dotatate treatment? Analysis of Progression Free Survival, Safety and Quality of Life in NETTER-1 study

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

Safety and efficacy of 68Ga-DOTATOC PET/CT in children and young adults

The Journal of nuclear medicine (1978), 2017-05, Vol.58, p.38

2017

Volltextzugriff (PDF)

Depth Psychology and Mysticism

1, 2018

Volltextzugriff (PDF)

Examination of PHOX 2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas

Histopathology, 2017-10, Vol.71 (4), p.503-510

2017

Volltextzugriff (PDF)

Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs

Neuroscience letters, 2009-08, Vol.460 (2), p.148-151

2009

Volltextzugriff (PDF)

Circulating tumor markers in patients with neuroendocrine tumors - a clinical perspective

International journal of endocrine oncology, 2015-03, Vol.2 (1), p.89-99

2015

Volltextzugriff (PDF)

Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study

Pancreas, 2018, Vol.47 (3), p.337

2018

Volltextzugriff (PDF)

Abstract 1368: RABL6A, a novel critical regulator of Akt-mTOR signaling in pancreatic neuroendocrine tumor cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1368-1368

2017

Volltextzugriff (PDF)

A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon

Regulatory peptides, 2003-06, Vol.114 (1), p.51-60

2003

Volltextzugriff (PDF)

Reply to, “RET Germline Mutations in Codon 609 and MEN2A Phenotype: Are They All Created Equal?” by Machens and Dralle (ASO-2009-06-0652)

Annals of surgical oncology, 2010, Vol.17 (1), p.333-333

2010

Volltextzugriff (PDF)

Limitations of Somatostatin Scintigraphy in Primary Small Bowel NETs

The Journal of surgical research, 2014-05, Vol.190 (2), p.548-553

2014

Volltextzugriff (PDF)

The outcome of peptide receptor radionuclide therapy (PRRT) in North American patients with advanced well-differentiated neuroendocrine tumors (WD-NETs)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e14600-e14600

2012

Volltextzugriff (PDF)

The use of peptide receptor radionuclide therapy in patients with metastatic low-grade neuroendocrine tumors

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.308-308

2012

Volltextzugriff (PDF)

Circulating Biomarkers in Neuroendocrine Tumors of the Enteropancreatic Tract: Application to Diagnosis, Monitoring Disease, and as Prognostic Indicators: Gastroenteropancreatic System and Its Tumors: Part 1

Endocrinology and metabolism clinics of North America, 2010, Vol.39 (4)

2010

Volltextzugriff (PDF)

Comparison of hepatic artery embolization and selective internal radiation therapy for metastatic neuroendocrine tumors

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.332-332

2012

Volltextzugriff (PDF)

Safety and accuracy of 68 Ga-DOTATOC PET/CT in children and young adults with solid tumors

American journal of nuclear medicine and molecular imaging, 2017, Vol.7 (5), p.228

2017

Volltextzugriff (PDF)

The Utility of F-18 DOPA PET/CT in Identifying Unknown Site of Primary Neuroendocrine Disease

Pancreas, 2010-03, Vol.39 (2), p.281

2010

Volltextzugriff (PDF)

Clinical outcomes and predictive value of chromogranin A (CgA) and pancreastatin (PcSt) in liver-directed therapies (LDTs) for well-differentiated metastatic neuroendocrine tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e14620-e14620

2012

Volltextzugriff (PDF)

Expression of vascular endothelial growth factor receptor (VEGF-R) and CD31 receptor (CD31-R) in high-grade neuroendocrine carcinoma of the uterine cervix (cNEC) and its association with prognosis

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15580-e15580

2012

Volltextzugriff (PDF)

Phase I Trial of 90 Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors

Journal of Nuclear Medicine, 2010-10, Vol.51 (10), p.1524-1531

2010

Volltextzugriff (PDF)

Phase I Trial of ^sup 90^Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors

The Journal of nuclear medicine (1978), 2010-10, Vol.51 (10), p.1524

2010

Volltextzugriff (PDF)

Discordant Expression of Proliferating Cell Nuclear Antigen (PCNA) and Ki-67 Antigen in Carcinoid and Pancreatic Neuroendocrine Tumors (C&PET) Likely Indicates Enhanced DNA Repair

Pancreas, 2010-03, Vol.39 (2), p.274

2010

Volltextzugriff (PDF)

Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): A Single-Center Case Control Study

Pancreas, 2010-03, Vol.39 (2), p.279

2010

Volltextzugriff (PDF)

Relief of bowel-related symptoms with telotristat etiprate in octreotide refractory carcinoid syndrome: Preliminary results of a double-blind, placebo-controlled multicenter study

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4085-4085

2012

Volltextzugriff (PDF)

Relief of bowel-related symptoms with telotristat etiprate in octreotide refractory carcinoid syndrome: Preliminary results of a placebo-controlled, multicenter study

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.312-312

2012

Volltextzugriff (PDF)

26 – 50 von 177

Suche als RSS-Feed

Aktive Filter

ThemaHumans

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(162)

Publikationsform

Sprache

Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(49)
Science & Technology
(49)
Animals
(36)
Biological And Medical Sciences
(23)
Dogs
(21)
Psychology
(17)
Social Sciences
(17)
Arts & Humanities
(16)
Medical Sciences
(16)
Psychology, Multidisciplinary
(16)
Religion
(16)
Female
(15)
Surgery
(15)
Male
(14)
Neuroendocrine Tumors
(14)
Oncology
(14)
Tumors
(12)
Fundamental And Applied Biological Sciences. Psychology
(11)
Gastroenterology & Hepatology
(9)
Patients
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Does liver tumor burden affect the therapeutic effect of 177Lu-Dotatate treatment? Analysis of Progression Free Survival, Safety and Quality of Life in NETTER-1 study

Safety and efficacy of 68Ga-DOTATOC PET/CT in children and young adults

Depth Psychology and Mysticism

Examination of PHOX 2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas

Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs

Circulating tumor markers in patients with neuroendocrine tumors - a clinical perspective

Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study

Abstract 1368: RABL6A, a novel critical regulator of Akt-mTOR signaling in pancreatic neuroendocrine tumor cells

A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon

Reply to, “RET Germline Mutations in Codon 609 and MEN2A Phenotype: Are They All Created Equal?” by Machens and Dralle (ASO-2009-06-0652)

Limitations of Somatostatin Scintigraphy in Primary Small Bowel NETs

The outcome of peptide receptor radionuclide therapy (PRRT) in North American patients with advanced well-differentiated neuroendocrine tumors (WD-NETs)

The use of peptide receptor radionuclide therapy in patients with metastatic low-grade neuroendocrine tumors

Circulating Biomarkers in Neuroendocrine Tumors of the Enteropancreatic Tract: Application to Diagnosis, Monitoring Disease, and as Prognostic Indicators: Gastroenteropancreatic System and Its Tumors: Part 1

Comparison of hepatic artery embolization and selective internal radiation therapy for metastatic neuroendocrine tumors

Safety and accuracy of 68 Ga-DOTATOC PET/CT in children and young adults with solid tumors

The Utility of F-18 DOPA PET/CT in Identifying Unknown Site of Primary Neuroendocrine Disease

Clinical outcomes and predictive value of chromogranin A (CgA) and pancreastatin (PcSt) in liver-directed therapies (LDTs) for well-differentiated metastatic neuroendocrine tumors

Expression of vascular endothelial growth factor receptor (VEGF-R) and CD31 receptor (CD31-R) in high-grade neuroendocrine carcinoma of the uterine cervix (cNEC) and its association with prognosis

Phase I Trial of 90 Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors

Phase I Trial of ^sup 90^Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors

Discordant Expression of Proliferating Cell Nuclear Antigen (PCNA) and Ki-67 Antigen in Carcinoid and Pancreatic Neuroendocrine Tumors (C&PET) Likely Indicates Enhanced DNA Repair

Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): A Single-Center Case Control Study

Relief of bowel-related symptoms with telotristat etiprate in octreotide refractory carcinoid syndrome: Preliminary results of a double-blind, placebo-controlled multicenter study

Relief of bowel-related symptoms with telotristat etiprate in octreotide refractory carcinoid syndrome: Preliminary results of a placebo-controlled, multicenter study

Aktive Filter

Suchergebnisse filtern